8-K
filed November 5, 2024, 6:59 PM ET
ticker AHCO
CIK 0001725255
earnings
confidence high
sentiment positive
materiality 0.70
AdaptHealth Q3 net income $22.9M, revenue $805.9M; raises free cash flow guidance
AdaptHealth Corp.
2024-Q3 EPS reported
$0.27
revenue$2,404,330,000
- Net income attributable to AdaptHealth of $22.9M vs net loss of $454.1M in Q3 2023.
- Revenue $805.9M, up 0.2% YoY; Adjusted EBITDA $164.3M, up 1.9%.
- FY 2024 guidance updated: revenue $3.22-3.26B (down), adjusted EBITDA $655-675M (narrowed), free cash flow $175-195M (up from $160-180M).
- Year-to-date free cash flow $162.7M, more than double prior year's $76.6M.
- Completed sale of certain custom rehab assets during the quarter.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001628280-24-045113
- form_type
- 8-K
- ticker
- AHCO
- cik
- 0001725255
- company_name
- AdaptHealth Corp.
- filed_at
- 2024-11-05T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:09.372633+00:00
- generated_at
- 2026-05-30T05:25:03.913480+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001628280-24-045113
- json_url
- https://secwatch.observer/filing/0001628280-24-045113.json
- markdown_url
- https://secwatch.observer/filing/0001628280-24-045113.md
- text_url
- https://secwatch.observer/filing/0001628280-24-045113.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1725255/000162828024045113/0001628280-24-045113-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1725255/000162828024045113/ahco-20241105.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
IVF
INVO Fertility FY2025 revenue $6.84M (+5% YoY); net loss improves to $(5.3)M
INVO Fertility, Inc.
June 2, 2026, 8:40 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
POLA
Polar Power Q1 net loss narrows 86% to $178K; gross margin expands to 65.7%
Polar Power, Inc.
June 2, 2026, 8:30 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
CTRN
Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M
Citi Trends Inc
June 2, 2026, 6:58 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SIG
Signet Q1 sales $1.6B, SSS +1.8%; raises FY27 adjusted EPS guidance
SIGNET JEWELERS LTD
June 2, 2026, 6:54 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DG
Dollar General Q1 EPS $2.00 beats expectations; raises FY2026 EPS guidance
DOLLAR GENERAL CORP
June 2, 2026, 6:54 AM ET
earnings
Items 2.02, 5.07, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
HIVE
HIVE FY2026 revenue $297.8M (+158% YoY); GAAP net loss $148.4M
HIVE Digital Technologies Ltd.
June 2, 2026, 6:23 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DCI
Donaldson Q3 FY2026 sales $995.1M (+5.8%), adj. EPS $1.06 (+7.1%)
DONALDSON Co INC
June 1, 2026, 5:41 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
GMRS
GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B
GMR Solutions Inc.
June 1, 2026, 4:45 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.